TransMedics Group, Inc.TMDXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$133.59M
↑ 463% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-36.81M
Historical baseline
PeriodValueYoY Change
TTM$133.59M+265.0%
2024$-80.94M+57.9%
2023$-192.09M-232.8%
2022$-57.72M-78.3%
2021$-32.38M-5.4%
2020$-30.72M+5.3%
2019$-32.45M-22.9%
2018$-26.40M-13.0%
2017$-23.36M+8.7%
2016$-25.59M-